close

Enter

Log in using OpenID

Cell Culture Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
The global cell culture market is estimated to value over USD 25.4 billion and register a CAGR of over 10.8%from the forecast period 2019 to 2026. The rising demand for bioproduction has led to manufacturers aiming at commercialization and developme
Cell Culture Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
The global cell culture market is estimated to value over USD 25.4 billion and register
a CAGR of over 10.8%from the forecast period 2019 to 2026.
The rising demand for bioproduction has led to manufacturers aiming at
commercialization and development of many biopharmaceutical products such as
therapeutic, monoclonal antibody and vaccines is driving the market. Increasing
preference for single-use technologies and increasing funds for cell-based research is
accelerating the market growth. The rise in R&D activity is further expected to spur
the market.
The market is classified into by product, application, type, end-user, and region.
Based on type, the cell structure is segmented into sera, media & reagents, vessels
and bioreactor accessories. Sera, media & reagents are expected to hold a vast share
of the market. The rise in the purchase of sera, media, and reagents for multiple
biopharmaceutical production, toxicology and vaccine production is boosting the
market. Serum-free media eliminates the risk of contamination by viruses. Sera,
media, and reagents are an integral part of experiments related to cells as they
provide enhanced results.
In terms of application, biopharmaceutical production is expected to hold a major
share of the market. The expansion of prominent pharmaceutical companies and
increasing regulatory permissions for production of vaccines based on cell culture
remains the key factor responsible for the market escalation. Rising demand for
monoclonal antibodies is also fueling the growth of the market.
Based on end-users, pharmaceutical and biotechnology companies are expected to
showcase exponential growth owing to increasing demand for single-use
technologies and growing government approvals towards cell culture-based
vaccines. The presence of an ample number of pharmaceutical players is also
positively influencing the market.
In terms of regions, North America is the global leader of the market. Government
and private enterprises rising interest in vaccines related to cell culture and higher
investments in cell-based research are driving the growth of the market in the
region. Growing prevalence regarding the latest trends in cell culture technology and
rapid expansion of pharmaceutical industries is bolstering the market. Asia-Pacific
region is also expected to show significant growth due to strong support from the
governments of Japan, China, and India. The strategic developments made by
prominent players are expected to boost the presence of the market in Japan. The
increasing initiative by the Indian government to promote life science industry is
escalating the market in the region.
Prominent players of the market are Lonza, Becton, Dickinson, and Company,
Merck KGaA, Corning Incorporated, CellGenix GmbH, Eppendorf AG, PromoCell
GmbH, GE Healthcare, HiMedia Laboratories, Sartorius AG, InvivoGen and Irvine
Scientific.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=3357&page=requestsample
Competitive Landscape:
● Thermo Fisher Scientific in 2019 invested USD 150 million to expand its capacity
of lyophilized product development and sterile liquids. Their centres across Italy and
the US will have aseptic filling lines alongside isolator technology which will help in
strengthening the company's customer base worldwide
● Merck in 2018 opened its BioReliance biosafety testing lab in Singapore. Their
new lab will offer critical testing services which would further augment the market
FutureWise Key Takeaways
● According to our industry experts, single-use bioreactors are expected to witness
immense demand owing to the rising adoption of single-use technologies. Single-use
technologies offer benefits such as low price and low contamination risk. In addition,
the demand for mAbs is also fueling the demand of single-use bioreactors thus
propelling the market
● Europe is expected to be a high growth profit region owing to the growing
support of private investors and the government for R&D activity in countries like
Germany and France. Expansion of the life science industry in the UK is also positively
influencing the market
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=3357&page=askfordiscount
Global Cell Culture Market Segmentation
By Product
● Consumables
▪ Sera, Media and Reagents
▪ Vessels
▪ Bioreactor Accessories
● Equipment
▪ Supporting Equipment
▪ Bioreactors
▪ Storage Equipment
By Application
● Biopharmaceutical Production
● Diagnostics
● Drug Screening and Development
● Stem Cell Research
● Tissue Engineering & Regenerative Medicine
By End-User
● Pharmaceutical & Biotechnology Companies
● Hospitals and Diagnostic Laboratories
● Research Institutes
By Region
● North America
● Europe
● Asia Pacific
● Latin America
● Rest of the World
Objectives of the Study:
• To provide with an exhaustive analysis on the global cell culture market by product,
by application, by end-user, and by region
• To cater to comprehensive information on factors impacting market growth
(drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North
America, Europe, Asia Pacific, Latin America and the rest of the world
• To record evaluate and competitive landscape mapping- product
launches, technological advancements, mergers, and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and
core competencies
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitation
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.2 Secondary Data
2.2.1 Secondary Source
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.4 Market Size Estimation
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Cell Culture: Market Overview
4.2 Asia Pacific: Cell Culture Market Share, By End User and Country (2019)
4.3 Cell Culture Sera, Media, & Reagents Market, By Type (USD Billion)
4.4 Cell Culture Market, By Application, 2019 vs 2026 (USD Billion)
4.5 Cell Culture Market, By Product, 2019 vs 2026 (USD Billion)
4.6 Geographical Snapshot of the Cell Culture Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Awareness About the Benefits of Cell Culture-Based
Vaccines
5.2.1.2 Increasing Demand for Monoclonal Antibodies
5.2.1.3 Funding for Cell-Based Research
5.2.1.4 Growing Preference for Single-Use Technologies
5.2.1.5 Launch of Advanced Cell Culture Products
5.2.1.6 Growing Focus on Personalized Medicine
5.2.2 Market Restraints
5.2.2.1 High Cost of Cell Biology Research
5.2.2.2 Lack of Infrastructure for Cell-Based Research in Emerging
Economies
5.2.3 Market Opportunities
5.2.3.1 Growing Demand for 3D Cell Culture
5.2.3.2 Increased Risk of Pandemics and Communicable Diseases
5.2.3.3 Emerging Economies
6 Cell Culture Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Sera, Media, and Reagents
6.2.1.1 Media
6.2.1.1.1 Serum-Free Media
6.2.1.1.1.1 Lack of Sera Eliminates the Risk of
Contamination By Viruses
6.2.1.1.2 Classical Media & Salts
6.2.1.1.2.1 Classical Media is Commonly Used in Diagnostics
and Manufacturing
6.2.1.1.3 Stem Cell Culture Media
6.2.1.1.3.1 Stem Cell Culture Media Will Witness the Highest
Growth in the APAC Market
6.2.1.1.4 Specialty Media
6.2.1.1.4.1 Specialty Media is Suitable for Specific, Selective
Cell Types
6.2.1.2 Reagents
6.2.1.2.1 Supplements & Growth Factors
6.2.1.2.1.1 Supplements Such as Amino Acids Play A Key
Role in Inducing Cell Growth
6.2.1.2.2 Buffers & Chemicals
6.2.1.2.2.1 Chemical Buffers are Widely Used, But are
Expensive and Can Be Toxic
6.2.1.2.3 Cell Dissociation Reagents
6.2.1.2.3.1 Dissociation Reagents Can Be Enzymatic Or NonEnzymatic
6.2.1.2.4 Balanced Salt Solutions
6.2.1.2.4.1 Salt Solutions Find Wide Applications in Life
Sciences
6.2.1.2.5 Attachment & Matrix Factors
6.2.1.2.5.1 Development of Cells is Dependent on
Attachment Factors
6.2.1.2.6 Antibiotics/Antimycotics
6.2.1.2.6.1 Possibility of Toxicity and Contamination Risks
Make Long-Term Use of Antibiotics/Antimycotics Conditional
6.2.1.2.7 Contamination Detection Kits
6.2.1.2.7.1 Kits Provide Results in Hours, Much Faster Than
Direct Culture Methods
6.2.1.2.8 Cryoprotective Reagents
6.2.1.2.8.1 Inorganic Expansions are A Favored Strategy for
Companies in This Market
6.2.1.2.9 Other Cell Culture Reagents
6.2.1.3 Sera
6.2.1.3.1 Fetal Bovine Sera
6.2.1.3.1.1 Use of Fbs is Associated With Ethical Issues
6.2.1.3.2 Adult Bovine Sera
6.2.1.3.2.1 ABS is Used as A Biochemical Agent in Ivd
6.2.1.3.3 Other Animal Sera
6.2.2 Vessels
6.2.2.1 Roller/Roux Bottles
6.2.2.1.1 Roller Bottles Offer an Economical Means of Cultivating
Large Cell Volumes
6.2.2.2 Cell Factory Systems/Cell Stacks
6.2.2.2.1 Cell Stacks Require Special Handling Equipment and Skilled
Expertise
6.2.2.3 Multiwell Plates
6.2.2.3.1 Larger Well Formats Allow for Greater Culture Volumes
6.2.2.4 Flasks
6.2.2.4.1 Disposable Flasks are in Greater Demand Among End
Users
6.2.2.5 Petri Dishes
6.2.2.5.1 Wide Usage of Petri Dishes is Attributed to Their Ease of
Use
6.2.3 Bioreactor Accessories
6.3 Equipment
6.3.1 Supporting Equipment
6.3.1.1 Filtration Systems
6.3.1.1.1 Growing Research in Cell Biology is A Key Factor Driving
Market Growth
6.3.1.2 Cell Counters
6.3.1.2.1 Automated Cell Counters are Witnessing Growing Demand
6.3.1.3 Carbon Dioxide Incubators
6.3.1.3.1 Incubators Provide Control Over Atmospheric Conditions
for Best Effect
6.3.1.4 Centrifuges
6.3.1.4.1 Technological Advances have Enabled the Development of
Faster, More Effective Centrifuges
6.3.1.5 Autoclaves
6.3.1.5.1 Autoclaves Sterilize Equipment and Supplies for Use
6.3.1.6 Microscopes
6.3.1.6.1 Inverted Microscopes are Widely Used in Cell Culture
Processes
6.3.1.7 Biosafety Cabinets
6.3.1.7.1 Cabinets are Classified Into Three Classes Based on
Protection Offered
6.3.1.8 Other Supporting Equipment
6.3.2 Bioreactors
6.3.2.1 Conventional Bioreactors
6.3.2.1.1 Conventional Bioreactors Hold the Largest Share of the
Bioreactors Market
6.3.2.2 Single-Use Bioreactors
6.3.2.2.1 Convenience, Ease of Use, and Flexibility are Driving
Demand for Single-Use Bioreactors
6.3.3 Storage Equipment
6.3.3.1 Refrigerators & Freezers
6.3.3.1.1 Refrigerators & Freezers are Used for Both Short and
Long-Term Storage
6.3.3.2 Cryostorage Systems
6.3.3.2.1 Benefits of Long-Term Preservation of Cell Cultures are
Driving Market Growth
7 Cell Culture Market, By Application
7.1 Introduction
7.2 Biopharmaceutical Production
7.2.1 Therapeutic Proteins
7.2.1.1 Growing Applications of Recombinant Proteins to Drive This
Segment
7.2.2 Vaccine Production
7.2.2.1 Rising Incidence of Disease Outbreaks to Drive the Market for
Vaccine Production
7.3 Diagnostics
7.3.1 Cell Cultures are Used in the Diagnosis of Viral Diseases
7.4 Drug Screening and Development
7.5 Stem Cell Research
7.5.1 Stringent Regulations to Conduct Clinical Trials for New Stem Cell-Based
Therapies on Human Subjects is Restraining the Growth of This Segment
7.6 Tissue Engineering & Regenerative Medicine
7.7 Other Applications
8 Cell Culture Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Increasing Use of Single-Use Technologies is Driving the Growth of the
Cell Culture Market for This Segment
8.3 Hospitals and Diagnostic Laboratories
8.3.1 Increasing Awareness for the Diagnosis of Various Diseases to Drive This
Segment
8.4 Research Institutes
8.4.1 Increasing Government Funding for Research Projects and High
Prevalence of Cancer to Drive the Cell Culture Market for Research Institutes
8.5 Cell Banks
8.5.1 Increasing Awareness of Preserving Stem Cells to Drive This Segment
9 Cell Culture Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US to Dominate the North American Cell Culture Market
9.2.2 Canada
9.2.2.1 Advancement in the Field of Regenerative Medicine to Drive the
Cell Culture Market in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Increasing Investment By Various Key Players and Growing
Funding From Government Organizations to Drive the Market
9.3.2 France
9.3.2.1 Support From Government and Private Investors to Drive the
Market for Cell Culture in France
9.3.3 UK
9.3.3.1 Growth in the Life Science Industry to Drive the Market for Cell
Culture in the UK
9.3.4 Italy
9.3.4.1 Increasing Number of Cell Biology Seminars and Conferences to
Fuel the Adoption of Cell Culture Products
9.3.5 Spain
9.3.5.1 Increasing Funding From Private and Public Organizations to Aid
Market Growth
9.3.6 RoE
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Strategic Developments By Companies to Drive the Market for Cell
Culture in Japan
9.4.2 China
9.4.2.1 Government Initiatives and Strategic Initiatives By Key Players to
Strengthen the Biotechnology Industry in China
9.4.3 India
9.4.3.1 Growth Initiatives to Promote Life Science Industry to Drive the
Market for Cell Culture in India
9.4.4 RoAPAC
9.5 Rest of the World (RoW)
10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis, 2019
10.3 Competitive Scenario
10.3.1 Partnerships, Agreements, and Collaborations (2016–2019)
10.3.2 Product Launches (2016–2019)
10.3.3 Expansions (2016–2019)
10.3.4 Acquisitions (2016–2019)
10.4 Competitive Leadership Mapping (2019)
10.4.1 Vendor Inclusion Criteria
10.4.2 Vanguards
10.4.3 Innovators
10.4.4 Dynamic Players
10.4.5 Emerging Players
11 Company Profiles
(Business Overview, Products Offered, Recent Developments, FutureWise Insights)*
11.1 Becton, Dickinson and Company
11.2 Cellgenix
11.3 Corning
11.4 Danaher
11.5 Eppendorf
11.6 Fujifilm Irvine Scientific (Acquired By Fujifilm Corporation)
11.7 GE Healthcare (A Subsidiary of General Electric Company)
11.8 Hi-Media Laboratories
11.9 Invivogen
11.10 Lonza Group AG
11.11 Merck KGaA
11.12 Miltenyi Biotec
11.13 Promocell
11.14 Sartorius AG
11.15 Thermo Fisher Scientific
12 Research Finding and Conclusion
13 Appendix
13.1 Research Methodology
13.2 Research Data Source
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content